Delivers X-ray scanning tools for internal defect detection and factory-grade assurance workflows.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Glimpse develops scalable battery quality monitoring using X-ray CT scanning and software to detect defects in battery cells that aren’t visible through conventional tests. The company transforms what was once a costly lab procedure into a more efficient, continuous quality assurance platform for battery makers and buyers.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Glimpse Management Team
Glimpse Valuations & Financials
View real-time NPM data on Glimpse stock including daily Glimpse stock price estimates, valuation history, and historical share price information. Access Glimpse financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Glimpse pricing across six independent market signals. Looking for private company due diligence data sources on Glimpse? Get in touch to learn more.
Similar Companies
like Glimpse
Peptilogics
Healthcare & Life Sciences
Leverages artificial intelligence to design and develop peptide-based therapeutic drugs for treating serious diseases.
Caremerge
Healthcare & Life Sciences
Develops software that helps senior care providers manage resident information, communication, and care coordination.
Kernel
Healthcare & Life Sciences
Develops non-invasive neuroimaging systems aiming to measure, interpret, and improve brain health.
Glytec
Healthcare & Life Sciences
Empowers healthcare providers with AI-driven tools for optimized insulin dosing and systemic glucose management.
Caris Life Sciences
Healthcare & Life Sciences
A molecular science company developing and delivering technologies to revolutionize healthcare.
Amaros
Healthcare & Life Sciences
Provides actionable intelligence that unifies eye care data for smarter clinical decisions and research insights.
Veradermics
Healthcare & Life Sciences
Develops therapies which tackle common dermatology needs with novel, reliable drug solutions.
Fellow
Healthcare & Life Sciences
Delivers diagnostic semen analysis that processes mailed samples with AI‑backed validation and lab-grade accuracy.
Celea Therapeutics
Healthcare & Life Sciences
Biopharmaceutical company developing next-generation therapies for serious respiratory diseases.
FAQ
We have answers
Glimpse stock does not trade on public stock exchanges. Glimpse stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Glimpse stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Glimpse Stock does not trade on public stock exchanges. In order to sell Glimpse shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Glimpse does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Glimpse share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Glimpse stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Glimpse stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Glimpse stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Glimpse is a private company and has not had an IPO. There is currently no Glimpse IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Glimpse IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
